Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,930 | -1,260 | -890 | -520 | -2,020 |
| Depreciation Amortization | 160 | 90 | 60 | 30 | 230 |
| Accounts receivable | 283 | N/A | N/A | N/A | -220 |
| Other Working Capital | 320 | 450 | 50 | 30 | -940 |
| Other Operating Activity | -123 | 80 | 70 | 30 | 340 |
| Operating Cash Flow | $-1,290 | $-640 | $-710 | $-430 | $-2,610 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 7 |
| PPE Investments | -30 | -6 | 0 | 0 | -20 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -7 |
| Investing Cash Flow | $-30 | $-6 | $0 | $0 | $-20 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 72 | N/A | N/A | N/A | 1,336 |
| Other Financing Activity | -2 | 70 | 70 | 0 | -6 |
| Financing Cash Flow | $570 | $70 | $70 | $0 | $1,330 |
| Exchange Rate Effect | -10 | -8 | -10 | -6 | -5 |
| Beginning Cash Position | 1,000 | 1,000 | 1,000 | 1,000 | 2,300 |
| End Cash Position | 240 | 420 | 340 | 560 | 1,000 |
| Net Cash Flow | $-760 | $-580 | $-660 | $-440 | $-1,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,290 | -640 | -710 | -430 | -2,610 |
| Capital Expenditure | -30 | N/A | N/A | N/A | -28 |
| Free Cash Flow | -1,320 | -640 | -710 | -430 | -2,638 |